Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Travere Therapeutics Inc (TVTX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Travere Therapeutics's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
5.39 -0.06    -1.10%
15:59:59 - Closed. Currency in USD ( Disclaimer )
After Hours
5.45
+0.06
+1.11%
17:32:00 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 1,481,375
  • Bid/Ask: 5.45 / 5.82
  • Day's Range: 5.12 - 5.50
Travere Therapeutics 5.39 -0.06 -1.10%

TVTX Recent Sentiments

 
This page contains information on users’ sentiments for the Travere Therapeutics Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Apr 25, 2024 Tomasz Kotlarek   5.58 -3.41%
Mar 25, 2024 Enrique Be   7.71 Apr 19, 2024 @ 5.72 -25.81%
Feb 27, 2024 Enrique Be   8.28 Mar 22, 2024 @ 7.88 -4.83%
Feb 27, 2024 Enrique Be   8.28 Feb 27, 2024 @ 8.28 0.00%
Feb 26, 2024 LiquidBoogie Grini   7.87 Mar 04, 2024 @ 7.59 -3.56%
Feb 26, 2024 LiquidBoogie Grini   7.98 Feb 26, 2024 @ 7.95 -0.38%
Feb 16, 2024 orlando costa   9.00 Feb 19, 2024 @ 8.20 -8.89%
Feb 14, 2024 Lars Ingebrigtsen   8.05 Mar 08, 2024 @ 8.66 +7.58%
Feb 13, 2024 LiquidBoogie Grini   8.12 Feb 19, 2024 @ 8.20 +0.99%
Feb 09, 2024 orlando costa   8.47 Feb 12, 2024 @ 8.70 +2.72%
Jan 23, 2024 mertz1966   9.05 Jan 29, 2024 @ 8.78 -2.98%
Jan 16, 2024 LiquidBoogie Grini   9.05 Jan 22, 2024 @ 8.86 -2.10%
Jan 11, 2024 LiquidBoogie Grini   9.16 Jan 15, 2024 @ 9.53 +4.04%
Dec 22, 2023 bhanu mallam   9.16 Dec 25, 2023 @ 9.06 -1.09%
Dec 11, 2023 Levent Sezgin   8.60 Jan 05, 2024 @ 8.64 +0.47%
Dec 08, 2023 Hector Rivera   8.76 Dec 22, 2023 @ 8.63 -1.48%
Dec 08, 2023 Fernando Adrian...   8.98 Dec 11, 2023 @ 8.68 -3.34%
Dec 07, 2023 alexandre de almeida   7.78 Dec 11, 2023 @ 8.68 +11.57%
Dec 06, 2023 Baptiste Ménard   7.88 Dec 29, 2023 @ 8.99 +14.09%
Dec 06, 2023 Yusuf Caner   7.95 Dec 29, 2023 @ 8.99 +13.08%
Dec 05, 2023 mertz1966   7.53 Dec 11, 2023 @ 8.68 +15.27%
Dec 05, 2023 Juri Haupt   7.76 Dec 29, 2023 @ 8.99 +15.85%
Nov 13, 2023 Levent Sezgin   5.75 Dec 08, 2023 @ 8.64 +50.26%
Oct 27, 2023 Sina Ender Kitapci   6.81 Nov 30, 2023 @ 6.39 -6.17%
Sep 26, 2023 Jesus Garcia   8.72 Oct 04, 2023 @ 8.28 +5.05%
Sep 25, 2023 Gökhan Korkmaz   7.94 Nov 30, 2023 @ 6.39 +19.52%
Sep 21, 2023 Freddy De Meersman   7.71 Nov 30, 2023 @ 6.39 -17.12%
Sep 21, 2023 fewzi aslan   7.63 Nov 30, 2023 @ 6.39 -16.25%
Sep 21, 2023 Jesus Garcia   7.67 Sep 26, 2023 @ 8.31 +8.34%
Aug 22, 2023 Khaled Karame   12.85 Nov 30, 2023 @ 6.39 -50.27%
Feb 21, 2023 Hidayet Easy   21.11 Mar 17, 2023 @ 21.20 +0.43%
Feb 21, 2023 Paolo Causarano   19.94 Mar 17, 2023 @ 21.20 +6.32%
Feb 17, 2023 Andreas Schatz   18.75 Mar 10, 2023 @ 20.73 +10.56%
Aug 16, 2021 Татьяна Салимова   17.92 Sep 10, 2021 @ 23.55 +31.42%
Aug 16, 2021 Andrew Wang   17.78 Aug 23, 2021 @ 21.18 -19.12%
Aug 16, 2021 Alexandr Yakovlev   18.75 Sep 10, 2021 @ 23.55 +25.60%
Aug 16, 2021 אורי רינות   18.39 Sep 10, 2021 @ 23.55 +28.06%
Aug 16, 2021 MFO Ambi   18.45 Sep 10, 2021 @ 23.55 -27.64%
Aug 16, 2021 רונן בן חמו   19.01 Sep 10, 2021 @ 23.55 +23.88%
Aug 16, 2021 Светлана Янкович   19.04 Sep 10, 2021 @ 23.55 +23.69%
Jun 09, 2021 mike yo   14.82 Jul 02, 2021 @ 15.32 +3.37%
Jun 02, 2021 Cyrus Malekani   14.28 Jun 25, 2021 @ 15.74 +10.22%
Jun 02, 2021 Cyrus Malekani   14.28 Jun 25, 2021 @ 15.74 +10.22%
Jun 02, 2021 Олег Шнаров   14.03 Jun 25, 2021 @ 15.74 -12.19%
May 27, 2021 Uygar Hangun   14.53 May 28, 2021 @ 15.23 +4.82%
May 26, 2021 Andreas Schatz   15.03 Jun 18, 2021 @ 15.84 +5.39%
May 26, 2021 Икром Ссс   15.04 Jun 18, 2021 @ 15.84 +5.32%
Nov 09, 2020 Johan Carranza   21.49 Dec 04, 2020 @ 25.09 -16.75%
May 29, 2020 Shaul Shalit   15.52 Jun 19, 2020 @ 15.79 +1.74%
Nov 27, 2019 Антон Емельянов   13.62 Dec 12, 2019 @ 13.80 +1.32%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

TVTX Comments

Write your thoughts about Travere Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email